regorafenib in colorectal cancer: optimizing the dose
Published 8 years ago • 923 plays • Length 3:53Download video MP4
Download video MP3
Similar videos
-
5:53
redos trial: optimizing regorafenib dosing in metastatic colorectal cancer
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
7:08
the regorafenib dose optimization study
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
5:32
colorectal cancer: regorafenib patient selection and dosing
-
8:26
regorafenib in advanced colorectal cancer: dosing strategies
-
9:34
regorafenib in colorectal cancer
-
10:02
role of the multikinase inhibitor regorafenib in metastatic colorectal cancer
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
5:31
practical advice for using regorafenib
-
3:54
colorectal cancer: patient follow-up with regorafenib
-
1:05
dr. corcoran on the utility of regorafenib in crc
-
8:18
the optimal dosing strategy for regorafenib in mcrc
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
7:46
clinical use of regorafenib in mhcc
-
7:35
use of regorafenib in refractory mcrc
-
1:47
dr. axel grothey on the time course of regorafenib-associated adverse events
-
3:14
when you have decided to prescribe regorafenib